Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

NCT00633529

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Cancer Centers of Florida Ocoee, Florida, United States
  • Central Indiana Cancer Centers Indianapolis, Indiana, United States
  • New York Oncology Hematology P.C. Albany, New York, United States
  • Mary Crowley Medical Research Center Dallas, Texas, United States
View Trial Details
Completed

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

NCT01038804

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Kenmar Research Institute Los Angeles, California, United States
  • Bay Area Cancer Research Group Pleasant Hill, California, United States
  • Lakeland Regional Cancer Center Lakeland, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 30 locations
View Trial Details
Completed

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

NCT00395070

Conditions
Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
Locations
  • Location #40 Tucson, Arizona, United States
  • Location #9 Little Rock, Arkansas, United States
  • Location #1 Bakersfield, California, United States
  • Location #24 San Diego, California, United States
View all 88 locations
View Trial Details
Completed

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

NCT00831636

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • U.Z. Gasthuisberg, Gynecologic Oncology, Herestraat 49 Leuven, Belgium
  • Medical Oncology C, National Cancer Institute, Centro di Riferimento Oncologico Aviano (PN), Italy
  • Medical Oncology B, National Cancer Institute, Via Mariano Semmola Naples, Italy
  • Department of Oncology, Catholic University of the Sacred Heart Rome, Italy
View Trial Details
Completed

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

NCT00498836

Conditions
Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
  • Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States
  • The Norwegian Radium Hospital Oslo, Norway
  • Lund University Hospital Lund, Sweden
View Trial Details

Related conditions